Community Pharmacy England News

- 14TH MAY 2025
- 0 COMMENTS
Retrospective reimbursement price adjustments for March 2025
Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has retrospectively adjusted the reimbursement prices of certain products dispensed in March 2025. Under the current price change mechanism, pharmacy owners would have to wait one (or in some cases two months) before any NHS list prices changes are applied to reimbursement of branded products. The delays in reimbursement prices catching
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 14TH MAY 2025
- 0 COMMENTS
Promoting NHS prescription prepayment certificates
Pharmacy teams can help to raise awareness by displaying posters in their pharmacy to remind patients about the savings they can make with prepayment certificates (PPCs). PPCs offer savings for those needing multiple prescription items or when a patient is prescribed a listed HRT medicine. The cost of each type of PPC has been frozen for
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 13TH MAY 2025
- 0 COMMENTS
MHRA Class 4 Medicines Defect Notification: Various Chemidex Pharma Ltd Products
MHRA Class 4 Medicines Defect Notification: Various Chemidex Pharma Ltd Products Drug alert number: EL(25)A/21 Date issued: 13 May 2025 Chemidex Pharma Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in their topical steroid products does not contain all the required safety information. Cartons for the products/batches listed are missing side effect information
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 9TH MAY 2025
- 0 COMMENTS
PQS: One week left to claim the Aspiration payment
Pharmacy owners have one week left to claim an Aspiration payment for the Pharmacy Quality Scheme (PQS) 2025/26 as the window for claiming this payment closes at 11.59pm on Friday 16th May 2025. The Aspiration payment is optional; if pharmacy owners do not want to claim it, it will not impact on the pharmacy owner’s
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 8TH MAY 2025
- 0 COMMENTS
MHRA Class 4 Medicines Defect Notification: Chloramphenicol 1% w/w Eye Ointment, Blumont Pharma Limited
MHRA Class 4 Medicines Defect Notification: Chloramphenicol 1% w/w Eye Ointment, Blumont Pharma Limited Drug alert number: EL(25)A/20 Date issued: 08 May 2025 Blumont Pharma Limited has informed the MHRA of an error with the European Article Number (EAN) barcode on the cartons of the batch of Chloramphenicol 1% w/w Eye Ointment (POM version only) in
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 7TH MAY 2025
- 0 COMMENTS
MHRA Drug Safety Update: Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor) risk of psychological side effects
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued guidance regarding the risk of psychological side effects while taking Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor). Psychological side effects such as anxiety, low mood, sleep disturbance, poor concentration, and forgetfulness have been infrequently reported in people with cystic fibrosis treated with Kaftrio. Healthcare professionals should advise patients
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 7TH MAY 2025
- 0 COMMENTS
Medicine Supply Notification: Buprenorphine (Reletrans® ) 5micrograms/hour and 15micrograms/hour transdermal patches
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Buprenorphine (Reletrans®) 5micrograms/hour and 15micrograms/hour transdermal patches. MSN/2025/030 Tier 2 – medium impact Date of issue: 7th May 2025 Buprenorphine (Reletrans®) 5micrograms/hour and 15micrograms/hour transdermal patches are out of stock until early July 2025. Alternative brands of buprenorphine matrix patches (Bunov®,
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 7TH MAY 2025
- 0 COMMENTS
Medicine Supply Notification: Lidocaine (Xylocaine® ) 10mg/dose spray sugar free
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Lidocaine (Xylocaine®) 10mg/dose spray sugar free. MSN/2025/028 Tier 2 – medium impact Date of issue: 7th May 2025 Lidocaine (Xylocaine®) 10mg/dose spray sugar free is out of stock from mid-May until late June 2025. Lidocaine 5% / Phenylephrine 0.5% nasal spray
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 6TH MAY 2025
- 0 COMMENTS
Funding & Reimbursement Shorts: Prescription switching
As part of our Funding & Reimbursement Shorts series, Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video on prescription switching. In this video, Alisha Khatri and Sarah Welbourne from our Dispensing and Supply Team discuss the topic of prescription switching to explain: What prescription switching is and why FP10 paper prescriptions
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 1ST MAY 2025
- 0 COMMENTS
Ivermectin 3mg tablets and Paxlovid 150mg/100mg tablets added to the Discount Not Deducted (DND) list from May 2025
Community Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 2 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 May 2025. This takes the total
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News

Retrospective reimbursement price adjustments for March 2025

Promoting NHS prescription prepayment certificates

MHRA Class 4 Medicines Defect Notification: Various Chemidex Pharma Ltd Products

PQS: One week left to claim the Aspiration payment

MHRA Class 4 Medicines Defect Notification: Chloramphenicol 1% w/w Eye Ointment, Blumont Pharma Limited

MHRA Drug Safety Update: Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor) risk of psychological side effects

Medicine Supply Notification: Buprenorphine (Reletrans® ) 5micrograms/hour and 15micrograms/hour transdermal patches

Medicine Supply Notification: Lidocaine (Xylocaine® ) 10mg/dose spray sugar free

Funding & Reimbursement Shorts: Prescription switching

Ivermectin 3mg tablets and Paxlovid 150mg/100mg tablets added to the Discount Not Deducted (DND) list from May 2025

Get in Touch

Working together with key healthcare stakeholders, local councils and other healthcare organisations as necessary to ensure that the provision of pharmaceutical services continues to be an integral part of Health and Social Care